Disorders of Sex Development: Genetics, diagnosis, Informing Clinical Care

Sinclair, Andrew H (Primary Chief Investigator (PCI))
Koopman, Peter A. (Chief Investigator (CI))
Harley, Vincent (Chief Investigator (CI))

Hudson Institute - Centre for Reproductive Health

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/19

Funding

National Health & Medical Research Council (NHMRC): AUD1,601,285.00

Related content

Research Output

Uterine SOX17: a key player in human endometrial receptivity and embryo implantation

Research output: Contribution to journal › Article › Research › peer-review

Testis determination requires a specific FGFR2 isoform to repress FOXL2

Research output: Contribution to journal › Article › Research › peer-review

Genetic Link Between Gender Dysphoria and Sex Hormone Signaling

Research output: Contribution to journal › Article › Research › peer-review

The Role of Copy Number Variants in Disorders of Sex Development

Research output: Contribution to journal › Review Article › Research › peer-review

Retinoic Acid Antagonizes Testis Development in Mice

Research output: Contribution to journal › Article › Research › peer-review

FGFR2 mutation in 46,XY sex reversal with craniosynostosis

Research output: Contribution to journal › Article › Research › peer-review

Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9

Research output: Contribution to journal › Article › Research › peer-review

Review disorders of sex development: The evolving role of genomics in diagnosis and gene discovery

Research output: Contribution to journal › Review Article › Research › peer-review